Objective. Analysis of skull thickness at the area of halo pin insertion site.
Summary of Background Data. Halo orthosis is a device used for providing stable fixation
of instability of cervical spine injury. Although this device can be applied quickly and safely, complications do occur. While clinical experiences have informed us that cranial bone thickness varies with age.
Methods. Coronal computerized tomography scans of 415 heads of patients who had no head injury, skull fracture, or craniofacial abnormalities were reviewed. All scans were performed with a Philips CX/Q. The patients’ ages were between 15 days and 89 years. Measurements were taken directly from the computer console, using the measure mode function. These measurements were obtained in millimeters at the locations where halo pins would normally be placed. Statistical analyses within and between selleck compound all age groups were performed using analysis of variance tests.
Results. The skull thickness increased with age at all sites measured. The average thickness of skull at the anterior midline varied from 5.62 mm (0-9 years) to 7.42 mm (80-89 years). The average thickness of the anterolateral
was from 5.52 to 8.54 mm, and the average thickness of the posterolateral was from 5.59 to 8.86 mm.
Conclusion. The thickness of skull at the halo pin insertion site gradually increases with age. Our study reveals that the thickness of skull reaches a steady peak in third to sixth decades. The thickness of skull at the anterior midline can be predicted by a simple linear regression equation: A = 7.302 + 0.014*age.”
“Chemical modification of LDL is a PCI-34051 nmr key event in atherogenesis. Modified LDL particles have the ability to act in all selleck kinase inhibitor stages of atherosclerosis. LDL modified by different mechanisms shares an increase of the negative charge of the particle. A subfraction of LDL with an increased electronegative charge – named electronegative LDL (LDL(-)) – has been reported in blood and can be considered as a pool of modified LDL particles in circulation. LDL(-) displays inflammatory and apoptotic properties,
is poorly recognized by LDL receptors and binds with high affinity to arterial proteoglycans. The proportion of LDL(-) in the blood is higher in patients who have a greater cardiovascular risk and active atherosclerosis. The heterogeneous origin of LDL(-) raises the possibility that its quantification could reflect the overall modification of LDL. Future studies conducted in large groups of patients are necessary to determine whether LDL(-) could be a useful biomarker to monitor the development of atherosclerosis.”
“This is the first report that presents renal transplantation after bilateral nephrectomy as the final treatment for severe renovascular hypertension due to fibromuscular dysplasia (FMD). We describe the history of a 1-year-old girl who suffered from renovascular hypertension due to FMD.